Uwe- Platzbecker


Ontology type: schema:Person     


Person Info

NAME

Uwe-

SURNAME

Platzbecker

Publications in SciGraph latest 50 shown

  • 2022-07-23 Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2022-07-22 Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis in LEUKEMIA
  • 2022-07-11 A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries in BLOOD CANCER JOURNAL
  • 2022-07-08 Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2022-06-22 The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms in LEUKEMIA
  • 2022-05-21 Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies in BMC CANCER
  • 2022-05-13 Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2022-04-20 RETRACTED ARTICLE: Einsatz von künstlicher Intelligenz im Management akuter Leukämien in DIE ONKOLOGIE
  • 2022-02-26 Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis in LEUKEMIA
  • 2022-02-22 Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears in BMC CANCER
  • 2022-02-18 Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15 in BONE MARROW TRANSPLANTATION
  • 2022-01-18 Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes in SCIENTIFIC REPORTS
  • 2021-12-14 Künstliche Intelligenz in der Hämatologie in INFO HÄMATOLOGIE + ONKOLOGIE
  • 2021-12-06 Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial in NATURE MEDICINE
  • 2021-11-16 Publisher Correction: Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study in LEUKEMIA
  • 2021-11-13 Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries in LEUKEMIA
  • 2021-11-03 Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML in TRIALS
  • 2021-07-15 Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2021-07-08 80/m mit zunehmender Belastungsdyspnoe und Abgeschlagenheit in DIE ONKOLOGIE
  • 2021-06-28 rhG-CSF plus Decitabin verhindert Rückfall bei Hochrisiko-AML nach erfolgreicher allo-HSCT in IM FOKUS ONKOLOGIE
  • 2021-06-25 Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms in LEUKEMIA
  • 2021-06-15 Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patterns in LEUKEMIA
  • 2021-05-28 Current challenges and unmet medical needs in myelodysplastic syndromes in LEUKEMIA
  • 2021-05-19 Management of Acute Promyelocytic Leukemia in ACUTE MYELOID LEUKEMIA
  • 2021-05-17 Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells in LEUKEMIA
  • 2021-05-04 Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes in NATURE MEDICINE
  • 2021-04-29 Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation in BLOOD CANCER JOURNAL
  • 2021-04-28 Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients in CLINICAL EPIGENETICS
  • 2021-04-28 Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis in BONE MARROW TRANSPLANTATION
  • 2021-04-12 Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients in CLINICAL EPIGENETICS
  • 2021-04-06 Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT in BONE MARROW TRANSPLANTATION
  • 2021-02-18 Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial in LEUKEMIA
  • 2021-02-09 Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes in NATURE MEDICINE
  • 2021-01-12 Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV) in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2020-12-01 Correction: CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC in LEUKEMIA
  • 2020-11-19 ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2020-08-29 Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML in ANNALS OF HEMATOLOGY
  • 2020-08-14 Hematopoietic Cell Transplantation for MDS Patients in DIAGNOSIS AND MANAGEMENT OF MYELODYSPLASTIC SYNDROMES
  • 2020-08-03 Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes in NATURE MEDICINE
  • 2020-07-25 Disease management of patients with immune thrombocytopenia—results of a representative retrospective survey in Germany in ANNALS OF HEMATOLOGY
  • 2020-07-24 Biotechnologische Innovationen im Bereich zellulärer Therapien in FORUM
  • 2020-07-13 Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients in LEUKEMIA
  • 2020-06-29 Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS in LEUKEMIA
  • 2020-06-25 High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2020-06-19 A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy in LEUKEMIA
  • 2020-06-06 Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia in ANNALS OF HEMATOLOGY
  • 2020-04-06 Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome in NATURE CELL BIOLOGY
  • 2020-03-16 Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study in LEUKEMIA
  • 2020-03-06 Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients in BONE MARROW TRANSPLANTATION
  • 2020-02-21 The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index in LEUKEMIA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.411339.d", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4488.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.446907.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.461742.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5963.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9122.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413591.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412460.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5596.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239826.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412282.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411544.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10253.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10417.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420036.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418936.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9647.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459950.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413328.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411327.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.492206.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.48769.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412688.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.13097.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418500.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5361.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.24704.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.270240.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15485.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412725.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7497.d", 
            "type": "Organization"
          }
        ], 
        "familyName": "Platzbecker", 
        "givenName": "Uwe-", 
        "id": "sg:person.0670313557.25", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0003-1863-3239"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670313557.25", 
          "https://orcid.org/0000-0003-1863-3239"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-09-02T16:35", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/person/person_914.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0670313557.25'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0670313557.25'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0670313557.25'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0670313557.25'


     

    This table displays all metadata directly associated to this object as RDF triples.

    81 TRIPLES      11 PREDICATES      43 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.0670313557.25 schema:affiliation N37b70e38b79644a3ba409eb1ffccaf26
    2 grid-institutes:grid.10253.35
    3 grid-institutes:grid.10417.33
    4 grid-institutes:grid.13097.3c
    5 grid-institutes:grid.15485.3d
    6 grid-institutes:grid.239826.4
    7 grid-institutes:grid.24704.35
    8 grid-institutes:grid.270240.3
    9 grid-institutes:grid.411327.2
    10 grid-institutes:grid.411544.1
    11 grid-institutes:grid.412282.f
    12 grid-institutes:grid.412460.5
    13 grid-institutes:grid.412688.1
    14 grid-institutes:grid.412725.7
    15 grid-institutes:grid.413328.f
    16 grid-institutes:grid.413591.b
    17 grid-institutes:grid.418500.8
    18 grid-institutes:grid.418936.1
    19 grid-institutes:grid.420036.3
    20 grid-institutes:grid.446907.8
    21 grid-institutes:grid.4488.0
    22 grid-institutes:grid.459950.4
    23 grid-institutes:grid.461742.2
    24 grid-institutes:grid.48769.34
    25 grid-institutes:grid.492206.b
    26 grid-institutes:grid.5361.1
    27 grid-institutes:grid.5596.f
    28 grid-institutes:grid.5963.9
    29 grid-institutes:grid.7497.d
    30 grid-institutes:grid.9122.8
    31 grid-institutes:grid.9647.c
    32 schema:familyName Platzbecker
    33 schema:givenName Uwe-
    34 schema:identifier Na6b5c859924c44a4b92c0ad67cc5f223
    35 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670313557.25
    36 https://orcid.org/0000-0003-1863-3239
    37 schema:sdDatePublished 2022-09-02T16:35
    38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    39 schema:sdPublisher Nca14186746294ae0b08172a02a551df7
    40 sgo:license sg:explorer/license/
    41 sgo:sdDataset persons
    42 rdf:type schema:Person
    43 N37b70e38b79644a3ba409eb1ffccaf26 schema:affiliation grid-institutes:grid.411339.d
    44 sgo:isCurrent true
    45 rdf:type schema:OrganizationRole
    46 Na6b5c859924c44a4b92c0ad67cc5f223 schema:name orcid_id
    47 schema:value 0000-0003-1863-3239
    48 rdf:type schema:PropertyValue
    49 Nca14186746294ae0b08172a02a551df7 schema:name Springer Nature - SN SciGraph project
    50 rdf:type schema:Organization
    51 grid-institutes:grid.10253.35 schema:Organization
    52 grid-institutes:grid.10417.33 schema:Organization
    53 grid-institutes:grid.13097.3c schema:Organization
    54 grid-institutes:grid.15485.3d schema:Organization
    55 grid-institutes:grid.239826.4 schema:Organization
    56 grid-institutes:grid.24704.35 schema:Organization
    57 grid-institutes:grid.270240.3 schema:Organization
    58 grid-institutes:grid.411327.2 schema:Organization
    59 grid-institutes:grid.411339.d schema:Organization
    60 grid-institutes:grid.411544.1 schema:Organization
    61 grid-institutes:grid.412282.f schema:Organization
    62 grid-institutes:grid.412460.5 schema:Organization
    63 grid-institutes:grid.412688.1 schema:Organization
    64 grid-institutes:grid.412725.7 schema:Organization
    65 grid-institutes:grid.413328.f schema:Organization
    66 grid-institutes:grid.413591.b schema:Organization
    67 grid-institutes:grid.418500.8 schema:Organization
    68 grid-institutes:grid.418936.1 schema:Organization
    69 grid-institutes:grid.420036.3 schema:Organization
    70 grid-institutes:grid.446907.8 schema:Organization
    71 grid-institutes:grid.4488.0 schema:Organization
    72 grid-institutes:grid.459950.4 schema:Organization
    73 grid-institutes:grid.461742.2 schema:Organization
    74 grid-institutes:grid.48769.34 schema:Organization
    75 grid-institutes:grid.492206.b schema:Organization
    76 grid-institutes:grid.5361.1 schema:Organization
    77 grid-institutes:grid.5596.f schema:Organization
    78 grid-institutes:grid.5963.9 schema:Organization
    79 grid-institutes:grid.7497.d schema:Organization
    80 grid-institutes:grid.9122.8 schema:Organization
    81 grid-institutes:grid.9647.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...